Hyperhidrosis Treatment Market Expected to Reach $950.7 Million by 2031—Allied Market Research

According to a new report published by Allied Market Research, titled, “Hyperhidrosis Treatment Market," The hyperhidrosis treatment market was valued at $575.32 million in 2021, and is estimated to reach $950.7 million by 2031, growing at a CAGR of 5.1% from 2022 to 2031.

A disorder called hyperhidrosis disorder causes excessive sweating. This sweating can occur in unusual situations, such as in cooler weather, or without any trigger at all. Menopause or hyperthyroidism are two medical problems that can contribute to it. Hyperhidrosis can be uncomfortable. However, several treatment options can provide some relief. Sweating is a normal reaction to a variety of situations, including hot weather, strenuous exertion, stress, and emotions of fear or rage. An individual sweats more than normal and for no apparent cause in hyperhidrosis
Rise in patient population suffering from hyperhidrosis is the major factor that drives the hyperhidrosis treatment market growth. Many key market players have invested on R&D activities to launch and innovate new product for the treatment of hyperhidrosis, which propels the market growth. Furthermore, innovations, development of advanced technologies, key strategies adopted by the major market players, and increasing demand for topical treatment are the upcoming hyperhidrosis treatment market trends. However, less awareness among people about the treatment is expected to impede the market growth. Conversely, increase in demand in developing countries is a lucrative opportunity for the growth of the hyperhidrosis treatment market during the forecast period. .By type, the market is segmented into axillary hyperhidrosis palmar hyperhidrosis, plantar hyperhidrosis, and  others. The axillary hyperhidrosis segment generated maximum revenue in 2021, and is anticipated to witness highest CAGR during the forecast period, owing to high incidence of axillary hyperhidrosis and wide availability of its treatment.
Depending on treatment, the market is divided into botulinum toxin injection, topical treatment, and oral medication. The topical treatment segment dominated the hyperhidrosis treatment market size in 2021, and is expected to witness highest CAGR during the forecast period owing to rapid effects and cost-effective treatment. By age, the market is bifurcated into below 50 years and above 50 years. The below 50 years segment dominated the market in 2021, and is expected to witness highest CAGR during the forecast period owing to incidence of disease in more in below 50-year age group.
North America accounted for a majority of the global hyperhidrosis treatment market share in 2021, and is anticipated to remain dominant during the forecast period. This is attributed to technological advancements in hyperhidrosis treatment , high incidence of disease, and presence of key players in the region. However, Asia-Pacific is anticipated to witness notable growth owing to rise in patient population, development of healthcare infrastructure, and increase in investments projects in the region, thus, boosting the hyperhidrosis treatment industry.

  Key findings of the study
•    By type, the axillary hyperhidrosis segment was the highest contributor to the market in 2021.
•    By treatment, the topical treatment segment was the highest contributor to the market in 2021.
•    Depending on age, the below 50 years segment was highest contributor in 2021, and is expected to continue this trend during the forecast period.
•    Region wise, North America garnered the largest revenue share in 2021, whereas Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period.